Illustration of diverse people holding hands and forming a spiral shape on a blue background. The spiral tightens toward the center, symbolizing unity, connection, and community.

Working Together: Addressing Cardiometabolic Risk in Underserved Populations

Array

Activity Info

Join this important activity to enhance your ability to identify and manage cardiometabolic risk in underserved populations. Many patients face serious health risks like obesity, high blood sugar, and hypertension due to inconsistent screening and care. By improving your knowledge and skills in early intervention, both with medications and lifestyle changes, you can help prevent disease progression and make a real difference in patient outcomes. Take this opportunity to strengthen your impact as a clinician and provide better care where it’s needed most.

Accreditation:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Osteopathic Association (AOA) and The France Foundation (TFF). The AOA is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation:

The American Osteopathic Association (AOA) designates this program for a maximum of 1 AOA Category 1-B credit and will report CME credits commensurate with the physician’s participation in this program. AOA designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Learning Objectives

After completing this activity, learners will be able to

  • Discuss with patients the health risks associated with cardiometabolic risk factors, including the benefits of early intervention
  • Outline to patients the available therapeutic approaches which may positively impact their risk for development of cardiometabolic disease
  • Commit to utilizing available patient-centered strategies for risk assessment and multidisciplinary care for patients who may be at risk for cardiometabolic disorders such as diabetes, obesity, CVD, and CKD

Faculty

Eden Miller, DO
Founder, Diabetes Nation
CEO, Diabetes Obesity Care
Bend, OR

Kevin Miller, DO
Co-Founder, Diabetes Nation
Co-Founder, Diabetes and Obesity Care
Bend, OR

Jay Shubrook, DO
Professor, Primary Care Department
College of Osteopathic Medicine
Touro University
Vallejo, CA

Original and last review release date: 3/31/25
Expiration date: 3/30/26
Estimated time to complete activity: 1 hour

STATEMENT OF NEED/DESCRIPTION OR SUMMARY OF GAP ANALYSIS

Join this important activity to enhance your ability to identify and manage cardiometabolic risk in underserved populations. Many patients face serious health risks like obesity, high blood sugar, and hypertension due to inconsistent screening and care. By improving your knowledge and skills in early intervention, both with medications and lifestyle changes, you can help prevent disease progression and make a real difference in patient outcomes. Take this opportunity to strengthen your impact as a clinician and provide better care where it’s needed most.

Target Audience

This activity is for osteopathic physicians and other health care professionals, including primary care professional (PCP) physicians, nurse practitioners (NPs), and physician associates (PAs) who are involved in the care of adult patients.

INSTRUCTIONAL FORMAT:

Online on-demand monograph consisting of interactive text, images, and audio.

Method of Participation:

There are no fees for participating in this CME activity. To participate in the activity, physicians will be required to take the following steps:

  • Read the learning objectives and faculty disclosures
  • Participate in the activity
  • Complete the pretest, posttest, and activity evaluation

Participants who successfully complete the evaluation and the posttest (scoring 70% or higher in a maximum of three attempts) will receive 1.0 Category 1-B CME credit or 1.0 AMA PRA Category 1 Credit(s)™.

Disclosures:

The American Osteopathic Association has implemented a policy to comply with the current Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education requiring mitigation of all conflicts of interest. Faculty declaring a relevant commercial interest must be identified in the activity syllabus and/or program.

In accordance with disclosure policies of AOA and ACCME, every effort has been made to ensure all CME activities are balanced, independent, objective, and scientifically rigorous. These policies include complying with ACCME’s Standards for Integrity and Independence in Accredited Continuing Education and mitigating all relevant conflicts of interest for all individuals in control of content.

Individuals with no relevant financial relationships

Name of Faculty or Presenter
Role(s)
Reported Financial Relationship (Name of Commercial Interest and Nature of Relationship)
Margaret Das, PhD
Medical content writer
No relevant financial disclosures
Heather Tarbox, MPH
TFF staff
No relevant financial disclosures
Emily Peck
TFF staff
No relevant financial disclosures
Heather Jastremski, MPH
AOA staff
No relevant financial disclosures
Darcy Steinberg
AOA staff
No relevant financial disclosures

Individuals with relevant financial relationships (all mitigated)

Name of Faculty or Presenter
Role(s)
Reported Financial Relationship
Eden Miller, DO
Steering committee member
Abbott (Grants/Research support)
Abbott, Bayer, BI, Corcept Therapeutics, Embecta, Eli Lilly, Insulet, Novo Nordisk (Consultant)
Abbott, Bayer, BI, Corcept Therapeutics, Embecta, Eli Lilly, Insulet, Novo Nordisk (Speakers Bureau)
Kevin Miller, DO
Steering committee member
Abbott (Grants/Research support)
Abbott, Bayer, BI, Corcept Therapeutics, Embecta, Eli Lilly, Insulet, Novo Nordisk (Consultant)
Abbott, Bayer, BI, Corcept Therapeutics, Embecta, Eli Lilly, Insulet, Novo Nordisk (Speakers Bureau)
Jay Shubrook, DO
Steering committee chair
Abbott, Bayer, Eli Lilly, Madrigal, Novo Nordisk, Sanofi (Non-CE Consulting)
Wolters Kluwers (Receives royalties)

Disclaimer:

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by the AOA. In no event will the AOA be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Commercial Support:

This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.